75228 Comparative Efficacy and Safety of Novel Biologics and Small-Molecule Therapies for Moderate-to-Severe Hidradenitis Suppurativa: A Systematic Review and Network Meta-Analysis
Journal of the American Academy of Dermatology · 2026-07 · 95 (1) · AB117
DOI: 10.1016/j.jaad.2026.04.477 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of the American Academy of Dermatology, 2026-07. Verfasst von Rachel Simpson und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Simpson, R., Cirone, K., Akrout, M., Toy, J., & Piguet, V. (2026). 75228 Comparative Efficacy and Safety of Novel Biologics and Small-Molecule Therapies for Moderate-to-Severe Hidradenitis Suppurativa: A Systematic Review and Network Meta-Analysis. Journal of the American Academy of Dermatology, 95(1), AB117. https://doi.org/10.1016/j.jaad.2026.04.477
Vancouver
Simpson R, Cirone K, Akrout M, Toy J, Piguet V. 75228 Comparative Efficacy and Safety of Novel Biologics and Small-Molecule Therapies for Moderate-to-Severe Hidradenitis Suppurativa: A Systematic Review and Network Meta-Analysis. Journal of the American Academy of Dermatology. 2026;95(1):AB117. doi:10.1016/j.jaad.2026.04.477
BibTeX
@article{Simpson2026,
author = {Simpson, Rachel and Cirone, Katrina and Akrout, Mohamed and Toy, Jeffrey and Piguet, Vincent},
title = {75228 Comparative Efficacy and Safety of Novel Biologics and Small-Molecule Therapies for Moderate-to-Severe Hidradenitis Suppurativa: A Systematic Review and Network Meta-Analysis},
journal = {Journal of the American Academy of Dermatology},
year = {2026},
volume = {95},
number = {1},
pages = {AB117},
doi = {10.1016/j.jaad.2026.04.477}
}
EUVIMED